Clinical Trials Browser

Suspended × Interventional × eltrombopag × Clear all

NCT06630221 2026-06-05

Eltrombopag as a Novel Therapeutic Approach for Low-risk MDS and CMML With TET2 Mutations

Phase 2 Suspended

MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myelomonocytic, Chronic

NCT04485416 2025-04-10

CCPO011

Phase 1 Suspended

Other solid neoplasm

Solid Tumor, Childhood